HAP Trading’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$351K Buy
+412,500
New +$1.16M 0.02% 309
2023
Q1
Sell
-14,800
Closed -$1K 1565
2022
Q4
$1K Sell
14,800
-4,900
-25% -$8.43K ﹤0.01% 1433
2022
Q3
$2K Buy
19,700
+3,700
+23% +$7.8K ﹤0.01% 1596
2022
Q2
$2K Buy
16,000
+1,600
+11% +$2.37K ﹤0.01% 1777
2022
Q1
$2K Sell
14,400
-9,200
-39% -$22.4K ﹤0.01% 2076
2021
Q4
$6K Buy
23,600
+7,800
+49% +$33.6K ﹤0.01% 2187
2021
Q3
$7K Sell
15,800
-6,200
-28% -$35.7K ﹤0.01% 2109
2021
Q2
$12K Buy
22,000
+7,900
+56% +$55.2K ﹤0.01% 1953
2021
Q1
$10K Sell
14,100
-44,600
-76% -$377K ﹤0.01% 1639
2020
Q4
$164K Buy
58,700
+24,200
+70% +$157K ﹤0.01% 1015
2020
Q3
$20K Buy
34,500
+8,300
+32% +$39.4K ﹤0.01% 1164
2020
Q2
$17K Buy
26,200
+11,800
+82% +$40.1K ﹤0.01% 1340
2020
Q1
$13K Buy
+14,400
New +$62.1K ﹤0.01% 986
2019
Q3
Sell
-36,100
Closed -$27K 1345
2019
Q2
$27K Buy
36,100
+17,700
+96% +$95.3K ﹤0.01% 840
2019
Q1
$5K Sell
18,400
-416,700
-96% -$2.89M ﹤0.01% 1007
2018
Q4
$80K Buy
435,100
+424,400
+3,966% +$4.76M 0.01% 678
2018
Q3
$16K Buy
+10,700
New +$159K ﹤0.01% 793
2017
Q1
Sell
-22,904
Closed -$3K 1212
2016
Q4
$3K Sell
22,904
-21,088
-48% -$587K ﹤0.01% 925
2016
Q3
$96K Buy
+43,992
New +$1.16M ﹤0.01% 602
2016
Q1
Sell
-58,118
Closed -$9K 998
2015
Q4
$9K Buy
+58,118
New +$1.96M ﹤0.01% 794
2015
Q2
Sell
-38,819
Closed -$663K 1127
2015
Q1
$663K Buy
+38,819
New +$1.39M 0.04% 298
2014
Q4
Sell
-137,070
Closed -$98K 1177
2014
Q3
$98K Sell
137,070
-18,101
-12% -$370K ﹤0.01% 677
2014
Q2
$475K Buy
+155,171
New +$3.15M 0.02% 455

Other funds holding PGEN

HAP Trading's PGEN Position: Q3 2019 in Review

HAP Trading sold out of Precigen (PGEN) in Q3 2019, closing a stake of 74,440 shares — an estimated $570K sold.

HAP Trading first reported a position in PGEN in Q4 2018 and held it in 3 quarters. The position peaked at $800K in Q4 2018. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2019.

  • HAP Trading reported no remaining Precigen position as of Q3 2019 after selling out during the quarter.
  • HAP Trading sold 74,440 Precigen shares in Q3 2019, an estimated $570K.
  • HAP Trading first reported a position in Precigen in Q4 2018 and held it in 3 quarters.
  • HAP Trading's Precigen position peaked at $800K in Q4 2018.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2019.

Based on HAP Trading's 13F filing for Q3 2019, filed 12 Nov 2019.